Billionaire Profile
G.V. Prasad
Global Rank
#2655

Image: Unsplash Contributor | Unsplash License | via Unsplash

G.V. Prasad

CEO, Pharmaceuticals
INDIA
Real-Time Net Worth
$1.494B
Estimated based on Pharmaceuticals stock value as of April 20, 2026
-0.25% (24h)
Age
65
Source
Pharmaceuticals
Industry
Healthcare
Citizenship
INDIA

Biography

G.V. Prasad is an Indian business executive and the Co-Chairman and Managing Director of Dr. Reddy's Laboratories, a global pharmaceutical company. Born in 1960, Prasad's career has been marked by significant achievements, including transforming Dr. Reddy's into a global generics powerhouse. His wealth source is pharmaceuticals, and his career began with co-founding Benzex Labs in 1985, later acquired by Dr. Reddy's. He subsequently became CEO of Cheminor Drugs Ltd. before the merger with Dr. Reddy's in 2001, where he took on the role of Vice-Chairman and CEO. His leadership emphasizes innovation, sustainability, and ethical practices, driving expansion into regulated markets and the launch of new initiatives. His current net worth is estimated at $1.6 Billion.

Fact Checked
Verified by Editorial Team
Live Data
Updated 4/20/2026

Wealth Over Time

In-Depth Profile

Early Life

G.V. Prasad was born in Nellore, Andhra Pradesh, India, in 1960. He attended Vidyaranya High School in Hyderabad and VR High School in Nellore. He studied chemical engineering at Alagappa College of Technology and later at the Illinois Institute of Technology in Chicago, earning a Bachelor of Science in Chemical Engineering in 1982. He pursued an MBA at Purdue University in 1983.

Rise to Success

Prasad's career in pharmaceuticals began in 1985 when he co-founded Benzex Labs, an API manufacturing company, later acquired by Dr. Reddy's Laboratories. He then served as CEO and MD of Cheminor Drugs Ltd. from 1990. In 2001, Cheminor Drugs merged with Dr. Reddy's, and Prasad became the Vice-Chairman and CEO. Under his leadership, Dr. Reddy's expanded globally, focusing on innovation and ethical practices. His focus on innovation led to the launch of new business platforms and expansion into regulated markets.

Key Business Strategies

Prasad is credited with transforming Dr. Reddy's Laboratories into a global generics leader. His strategies include emphasizing innovation, transparency, and business ethics. He has driven sustainable manufacturing practices, including the adoption of green technologies and processes. He has also spearheaded the company's expansion into new healthcare segments such as nutraceuticals and digital healthcare services.

Philanthropy

Prasad is involved in various philanthropic initiatives. He is a board member of the Dr. Reddy's Institute of Life Sciences. He has also been involved with the Andhra Pradesh chapter of the Worldwide Fund for Nature and the Acumen Fund, a non-profit venture focused on eliminating global poverty.

Career Milestones

1985

Co-founded Benzex Labs

Co-founded Benzex Labs, an API manufacturing company, which was later acquired by Dr. Reddy's Laboratories.

1990

CEO and MD of Cheminor Drugs Ltd.

Became CEO and Managing Director of Cheminor Drugs Ltd.

2001

Vice-Chairman and CEO of Dr. Reddy's Laboratories

Cheminor Drugs merged with Dr. Reddy's Laboratories, and Prasad became Vice-Chairman and CEO of the merged entity.

2026

Reappointed as Co-Chairman and Managing Director

Reappointed as Co-Chairman and Managing Director of Dr. Reddy's Laboratories for a five-year term.

Philanthropy & Social Impact

Education

Dr. Reddy's Foundation

Undisclosed

Supports the Dr. Reddy's Foundation.

Environmental Conservation

Worldwide Fund for Nature (WWF-India)

Undisclosed

Involved with the Andhra Pradesh chapter of WWF-India.

Poverty Alleviation

Acumen Fund

Undisclosed

Supports the Acumen Fund, which uses entrepreneurial approaches to eliminate global poverty.

Business Philosophy & Leadership

Leadership Principles

Innovation

Emphasizes innovation to drive growth and expand the company's business platforms.

Transparency and Business Ethics

Promotes ethical practices and transparency in business operations.

Sustainability

Leads sustainability initiatives, including adopting green technologies and processes.